O6-Methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: Results from the CCG-945 cohort

Journal of Clinical Oncology

Volumn 24, Issue 21, 2006, Pages 3431-3437

  Pollack, Ian F ^a   Hamilton, Ronald L ^a   Sobol, Robert W ^a   Burnham, Judith ^a   Yates, Allan J ^a   Holmes, Emiko J ^a   Zhou, Tianni ^a   Finlay, Jonathan L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYTARABINE; DACARBAZINE; HYDROXYUREA; LOMUSTINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; METHYLPREDNISOLONE; PREDNISONE; PROCARBAZINE; VINCRISTINE; ALKYLATING AGENT; TUMOR MARKER;

ADJUVANT THERAPY; AGE DISTRIBUTION; ARTICLE; ASTROCYTOMA; BRAIN EDEMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; TUMOR LOCALIZATION; ADOLESCENT; BRAIN TUMOR; CHILD; ENZYMOLOGY; GENE EXPRESSION REGULATION; GLIOMA; METABOLISM; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME; UPREGULATION;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 33746860420     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.05.7265     Document Type: Article

References (56)

1. Devaux BC, O'Fallon JR, Kelly PJ: Resection, biopsy, and survival in malignant glial neoplasms: A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 78:767-775, 1993
2. Pollack IF: Current concepts: Brain tumors in children. N Engl J Med 331:1500-1507, 1994
3. Chandler KL, Prados MD, Malec M, et al: Long-term survival in patients with glioblastoma multiforme. Neurosurgery 32:716-720, 1993
4. Salcman M, Scholtz H, Kaplan RS, et al: Long-term survival in patients with malignant astrocytoma. Neurosurgery 34:213-220, 1994
5. Salford LG, Brun A, Nirfalk S: Ten-year survival among patients with supratentorial astrocytoma grade III and IV. J Neurosurg 69:506-509, 1988
6. Duffner PK, Krischer JP, Burger PC, et al: Treatment of infants with malignant gliomas: The Pediatric Oncology Group experience. J Neurooncol 28:245-256, 1996
7. Bredel M, Pollack IF, Hamilton RL, et al: Epidermal growth factor receptor (EGFR) expression and gene amplification in high-grade non-brainstem gliomas of childhood. Clin Cancer Res 5:1786-1792, 1999
8. Cheng Y, Ng H-K, Zhang S-F, et al: Genetic alterations in pediatric high-grade astrocytomas. Hum Pathol 30:1284-1290, 1999
9. Raffel C, Frederick L, O'Fallon JR, et al: Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations. Clin Cancer Res 5:4085-4090, 1999
10. Sung T, Miller DC, Hayes RL, et al: Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas. Brain Pathol 10:249-259, 2000
11. Sure U, Ruedi D, Tachibana O, et al: Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. J Neuropathol Exp Neurol 56:782-789, 1997
12. Pollack IF, Finkelstein SD, Woods J, et al: Expression of p53 and prognosis in malignant gliomas in children. N Engl J Med 346:420-427, 2002
13. Pollack IF, Finkelstein SD, Burnham J, et al: The association between chromosome 1p loss and outcome in pediatric malignant gliomas: Results from the CCG-945 cohort. Pediatr Neurosurg 39: 114-121, 2003
14. Louis DN: A molecular genetic model of astrocytoma histopathology. Brain Pathol 7:755-764, 1997
15. INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res 55:4833-4836, 1995
16. von Deimling A, von Ammon K, Schoenfeld D, et al: Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 3:19-26, 1993
17. Galanis E, Buckner J, Kimmel D, et al: Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas. Int J Oncol 13:717-724, 1998
18. Watanabe K, Tachibana O, Sato K, et al: Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6:217-224, 1996
19. 1-S transition control gene abnormalities. Cancer Res 60:417-424, 2000
20. Collins VP: Progression as exemplified by human astrocytic tumors. Semin Cancer Biol 9:267-276, 1999
21. Sposto R, Ertel IJ, Jenkin RDT, et al: The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial - A report from the Children's Cancer Study Group. J Neurooncol 7:165-177, 1989
22. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
23. O'Reilly SM, Newlands ES, Glaser MG, et al: Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur J Cancer 29A:940-942, 1993
24. Gerson SL: MGMT: Its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer 4:296-307, 2004
25. Pegg AB: Mammalian O6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 50:6119-6129, 1990
26. Wedge SR, Porteus JK, May BL, et al: Potentiation of temozolomide and BCNU toxicity by O(6)-benzyl-guanine: A comparative study in vitro. Br J Cancer 73:482-490, 1996
27. Schold SC Jr, Brent TP, von Hofe E, et al: O6-alkylguanine-DNA alkyltransferase and of sensitivity to procarbazine in human brain tumor xenografts. J Neurosurg 70:573-577, 1989
28. Esteller M, Garcia-Foncillas J, Andion E, et al: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343:1350-1354, 2000
29. Hegi ME, Diserens A-C, Godard S, et al: Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 10:1871-1874, 2004
30. Hegi ME, Diserens A-C, Gorlia T, et al: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997-1003, 2005
31. Belanich M, Pastor M, Randall T, et al: Retrospective study of the correlation between DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res 56:783-788, 1996
32. Hotta T, Saito Y, Fujita H, et al: O6-alkylguanine-DNA alkyltransferase activity of human malignant glioma and its clinical implications. J Neurooncol 21:135-140, 1994
33. 6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolomide plus cisplatin in glioblastoma multiforme. Clin Cancer Res 9:1461-1468, 2003
34. Jaeckle KA, Eyre HJ, Townsend JJ, et al: Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis- chloroethylnitrosourea: A Southwest Oncology Group study. J Clin Oncol 16: 3310-3315, 1998
35. Silber JR, Blank A, Bobola MS, et al: O6-methylguanine DNA methyltransferase-deficient phenotype in human gliomas: Frequency and time to tumor progression after alkylating agent-based chemotherapy. Clin Cancer Res 5:807-814, 1999
36. Friedman HS, McLendon RE, Kerby T, et al: DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol 16:3851-3857, 1998
37. Finlay JL, Boyett JM, Yates AJ, et al: Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. J Clin Oncol 13:112-123, 1995
38. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741-748, 1991
39. 6-alkylguanine-DNA alkyltransferase using newly developed monoclonal antibodies. Cancer Res 50: 58-61, 1990
40. 6-methylguanine-DNA methyltransferase in formalin-fixed, paraffin-embedded astrocytomas. Lab Invest 78:643-644, 1998
41. Hsu S, Raine L, Fanger H, et al: Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 29:577-580, 1981
42. Pollack IF, Boyett JM, Yates AJ, et al: The influence of central review on outcome associations in childhood malignant gliomas: Results from the CCG-945 experience. Neuro-Oncol 5:197-207, 2003
43. Kleihues P, Burger PC, Scheithauer BW: Histological typing of tumours of the central nervous system, in Sobin LH (ed): International Histological Classification of Tumours (2nd ed). Berlin, Germany, Springer-Verlag, vol 21, 1993, pp 11-16
44. Kalbfleisch JD, Prentice RI: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley and Sons, 1980, pp 163-180
45. Dixon WJ, Massey FJ: Introduction to Statistical Analysis (ed 3). New York, NY, McGraw-Hill, 1969
46. Berg SL, Gerson SL, Godwin K, et al: Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and time course of peripheral blood mononuclear cell O6-methylguanine-DNA methyltransferase inhibition in the nonhuman primate. Cancer Res 55:4606-4610, 1995
47. Fujio C, Chang HR, Tsujimura T, et al: Hypersensitivity of human tumor xenografts lacking O6-alkylguanine-DNA alkyltransferase to the anti-tumor agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea. Carcinogenesis (Lond) 10:351-356, 1989
48. Bobola MS, Berger MS, Silber JR: Contribution of O6-methylguanine-DNA methyltransferase to resistance to 1,3-(2-chloroethyl)-1-nitrosourea in human brain tumor-derived cell lines. Mol Carcinog 13:81-88, 1995
49. Brent TP, Houghton PJ, Houghton JA: O6-alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-trans-(4-methylcyclohexyl)-1-nitrosourea. Proc Natl Acad Sci U S A 82:2985-2989, 1985
50. Middlemas DS, Stewart CF, Kirstein MN, et al: Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models. Clin Cancer Res 6:998-1007, 2000
51. Silber JR, Mueller BA, Ewers TG, et al: Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain. Cancer Res 53:3416-3420, 1993
52. Hongeng S, Brent TP, Sanford RA, et al: O6-methylguanine-DNA methyltransferase protein levels in pediatric brain tumors. Clin Cancer Res 3:2459-2463, 1997
53. Fritz G, Tano K, Mitra S, et al: Induction of the DNA repair gene encoding O6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments. Mol Cell Biol 11:4660-4668, 1991
54. Grombacher T, Mitra S, Kaina B: Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes. Carcinogenesis 17: 2329-2336, 1996
55. Quinn JA, Pluda J, Dolan ME, et al: Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma. J Clin Oncol 20: 2277-2283, 2002
56. Quinn JA, Desjardins A, Reardon D, et al: Phase II trial of temozolomide (Temodar) plus O6-benzylguanine (O6-BGI in the treatment of patients with Temodar-resistant malignant glioma. Neuro-Oncol 6:380, 2004 (abstr)